Health claims meeting
This article was originally published in The Tan Sheet
An FDA public meeting to assess consumer perceptions of health claims will be held Nov. 17 at the Center for Food Safety & Applied Nutrition Harvey Wiley Auditorium from 9 a.m. to 4:30 p.m., the agency announces in a Federal Register notice Oct. 19. The agency will present findings from research assessing consumer reactions to health claims and "address the implications of these studies for future research" evaluating the effect of health claims on consumer behavior. Those who wish to make presentations must register by Nov. 10. Comments also are being collected through Jan. 17. An FDA study on consumer reactions to health claims was recently released (1"The Tan Sheet" Oct. 10, 2005, p. 7)...
You may also be interested in...
"Report card grade disclaimers" used to distinguish the amount of scientific evidence backing a health claim may cause consumers to be more skeptical of the science behind unqualified health claims compared to qualified claims, according an FDA survey
The EU’s single-portal Clinical Trial Information System will become mandatory from 31 January 2023 for sponsors seeking clinical trial approval. Problems that some users have experienced while using the system voluntarily are being fixed, according to the European Medicines Agency.
Biodiversity footprinting may still be a new concept for pharmaceutical companies, but they need to put a clear supply chain strategy in place now, particularly as the COP 15 conference in December is expected to discuss mandatory reporting of biodiversity risks, says Luka Brown.